VTGN - Vistagen Therapeutics Inc. (VTGN) Q4 2024 Earnings Call Transcript
2024-06-11 18:41:02 ET
Vistagen Therapeutics, Inc. (VTGN)
Q4 2024 Earnings Conference Call
June 11, 2024 05:00 PM ET
Company Participants
Mark McPartland - Senior Vice President, Investor Relations
Shawn Singh - Chief Executive Officer
Cindy Anderson - Chief Financial Officer
Josh Prince - Chief Operating Officer
Conference Call Participants
Tim Lugo - William Blair
Presentation
Operator
Greetings, and welcome to the Vistagen Therapeutics Fiscal Year-End 2024 Corporate Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mark McPartland, Senior Vice President of Investor Relations.
Mark McPartland
Thank you, Joe. Good afternoon, everyone, and welcome to Vistagen's fiscal year-end 2024 corporate update conference call and webcast. This afternoon, we filed our annual report with the Securities Exchange Commission or SEC on SEC Form 10-K for our fiscal year ended March 31, 2024 and issued a press release providing an overview of our progress during our fiscal year 2024. We encourage you to review the press release and our 10-K, both of which can be found in the investor section of our website....
Vistagen Therapeutics, Inc. (VTGN) Q4 2024 Earnings Call Transcript